Nabriva Therapeutics (NBRV) Insider Trading & Ownership → Next President (Not Trump. Not Biden.) (From The Freeport Society) (Ad) Free NBRV Stock Alerts Add Compare Share Share Insider TradesStock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsTrendsStock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsTrends Nabriva Therapeutics (NASDAQ:NBRV) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage1.63%Number OfInsiders Buying(Last 3 Years)3Amount OfInsider Buying(Last 3 Years)$117,630.00Number OfInsiders Selling(Last 3 Years)2Amount OfInsider Selling(Last 3 Years)$2,376.72 Get NBRV Insider Trade Alerts Want to know when executives and insiders are buying or selling Nabriva Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address NBRV Insider Buying and Selling by Quarter Ad Porter & CompanyObama’s Forever Term [exposed]Over a decade ago, I tried to warn you... Because the same forces are once again brewing… and what’s coming next will forever reshape everything you think you know about America. Start streaming it now at no cost here Nabriva Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/1/2022Charles A Rowland JrDirectorSell8,496$0.17$1,444.32 12/28/2021Theodore R SchroederCEOBuy100,000$0.57$57,000.00 12/27/2021J. Christopher NaftzgerGeneral CounselBuy7,000$0.59$4,130.00 9/14/2021Theodore R. SchroederCEOBuy50,000$1.13$56,500.00 8/2/2021Stephen W. WebsterDirectorSell777$1.20$932.40 (Data available from 1/1/2013 forward) NBRV Insider Trading Activity - Frequently Asked Questions Who is on Nabriva Therapeutics's Insider Roster? The list of insiders at Nabriva Therapeutics includes Charles A Rowland Jr, J. Christopher Naftzger, Stephen W. Webster, Theodore R Schroeder. Learn more on insiders at NBRV. What percentage of Nabriva Therapeutics stock is owned by insiders? 1.63% of Nabriva Therapeutics stock is owned by insiders. Learn more on NBRV's insider holdings. Which Nabriva Therapeutics insiders have been selling company stock? The following insider sold NBRV shares in the last 24 months: Charles A Rowland Jr ($1,444.32). How much insider selling is happening at Nabriva Therapeutics? Insiders have sold a total of 8,496 Nabriva Therapeutics shares in the last 24 months for a total of $1,444.32 sold. More Insider Trading Tools from MarketBeat Related Companies: Aadi Bioscience Insider Transactions Immuneering Insider Transactions Gain Therapeutics Insider Transactions Ocuphire Pharma Insider Transactions Xilio Therapeutics Insider Transactions Acurx Pharmaceuticals Insider Transactions Clene Insider Transactions HCW Biologics Insider Transactions CASI Pharmaceuticals Insider Transactions NRx Pharmaceuticals Insider Transactions Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 3 Stocks Insiders are Buying That Should be on Your RadarInsider Trading is Good News for These Stocks4 Small-Cap Energy Stocks Insiders are Buying 3 Penny Stocks That Insiders Are BuyingThe 3 Hottest Insiders Buys This Month This page (NASDAQ:NBRV) was last updated on 5/29/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaHe Is Giving Away BitcoinCrypto Swap ProfitsA once-in-a-century investment opportunityStansberry ResearchWrite this ticker symbol down…StocksToTradeMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemWeiss RatingsTop 5 AI Stocks to Buy for 2024Market Moving Trends Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nabriva Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.